Searchable abstracts of presentations at key conferences in endocrinology

ea0026p569 | Cardiovascular endocrinology and lipid metabolism | ECE2011

α-Defensins are novel biomarkers of low grade inflammation with strong prognostic impact in patients with heart failure

Kistorp C , Christensen H M , Frystyk J , Flyvbjerg A , Hildebrandt P , Schou M , Faber J

Introduction: α-Defensins are recently described peptides, which are part of the innate immune system. Increased circulating levels are observed in conditions associated with chronic low grade inflammation, such as ischemic heart disease and in diabetes mellitus (DM). Recently we reported adverse prognostic implications of high α-defensins in patients with type 1 DM. However, it is not clear whether this finding may be generalized to include other groups such as pati...

ea0011p388 | Diabetes, metabolism and cardiovascular | ECE2006

Plasma N-terminal pro-brain natriuretic peptide and adiponectin levels increases during weight loss

Kistorp C , Bliddal H , Flyvbjerg A , Frystyk J , Hildebrandt P , Faber J

Objective: The cardiac hormone brain natriuretic peptide (BNP), including the N-terminal fragment of the prohormone (NT-proBNP) have in cross-sectional studies been demonstrated to be inversely associated with BMI. Clearance of these peptides by adipocyt specific receptors have been suggested. We therefore investigated the impact of weight loss on plasma levels of NT-proBNP and adiponectin in obese individuals.Methods: A total of 20 obese women and 2 men...

ea0029oc19.5 | Cardiovascular Endocrinology | ICEECE2012

Circulating adrenomedulin levels are associated with atrial natriuretic peptide and brain natriuretic peptide levels in heart failure patients

Holmager P. , Schou M. , Egstrup M. , Gustafsson I. , Goetze J. , Gustafsson F. , Hildebrandt P. , Faber J. , Kistorp C.

Introduction: Heart failure is characterised by an up-regulation of neurohoromones, and brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) are well-established diagnostic biomarkers with substancial prognostic value. Adrenomedullin is a vasoactive peptide and a potential biomarker of vascular injury in patients with cardiovascular disease (CVD) The aims of the present study were to investigate whether mid-regional pro adrenomedullin (MR-proADM) is predictive ...